CClinicalTrials.gg
CompletedNCT07623070Updated Jun 3, 2026

Gac Fruit Oil Supplementation for Visual Health and Sleep Quality

An interventional study of Gac Fruit Oil Capsules in Sleep Disturbance and Visual Health, sponsored by Yuanpei University of Medical Technology. Completed at 1 site in Taiwan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Yuanpei University of Medical Technology · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Sep 2022, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This study evaluated the effects of gac fruit oil supplementation on visual health, sleep quality, depressive symptoms, cognitive function, and brain imaging parameters in adults with sleep disturbance. Participants aged 40 to 65 years were recruited and received gac fruit oil capsules for 30 days. The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day. Assessments were performed before and after the intervention, including macular pigment measurement, ocular surface disease evaluation, tear film analysis, contrast sensitivity testing, accommodative microfluctuation analysis, optical coherence tomography, the Pittsburgh Sleep Quality Index, a depression scale, the Mini-Mental State Examination, and brain magnetic resonance imaging. The study aimed to explore whether 30 days of gac fruit oil supplementation was associated with changes in visual function, sleep quality, mood-related measures, cognitive function, and brain imaging findings.

02

Conditions studied

  • Sleep Disturbance
  • Visual Health

Keywords

  • Gac fruit oil
  • Momordica cochinchinensis
  • Sleep quality
  • Visual health
  • Depressive symptoms
03

In context

Parasomnias

757 studies on the registry are indexed under Parasomnias; 190 are open to participants now.

This study's enrollment of 50 is below the median of 66 across 570 interventional studies indexed under Parasomnias.

Browse Parasomnias studies →

Lead sponsor

Yuanpei University of Medical Technology is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 40 to 65 years.
  • Participants with sleep disturbance.
  • Participants who were willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • History of ocular surgery.
  • Cataract.
  • Glaucoma.
  • Current supplementation intended to increase macular pigment level.
  • Pregnancy.
  • Severe illness.
  • Use of medications that may affect or stimulate sleep.
  • Use of medications that promote sleep.
  • Unable to undergo magnetic resonance imaging, including but not limited to individuals with a pacemaker, artificial heart valve, metal aneurysm clip, metallic tracheostomy tube, possible metallic fragments in the orbit, cochlear implant, implanted electrodes, neurostimulator, implanted drug infusion device, hemostatic clips, vascular stents, claustrophobia, previous brain surgery, or history of traumatic brain injury with implanted metal materials.
  • Participants who experienced discomfort during the study or wished to withdraw could discontinue participation at any time without providing a reason.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Gac Fruit Oil Supplementation

    Participants received gac fruit oil capsules for 30 days. The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day.

    Dietary Supplement: Gac Fruit Oil Capsules

Interventions

  • Dietary supplementGac Fruit Oil Capsules

    Participants took gac fruit oil capsules orally for 30 days. The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day, for a total of four capsules per day.

    Also known as: Momordica cochinchinensis Oil Capsules

06

What researchers measure

Primary outcomes

  1. Change in Sleep Quality

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

Secondary outcomes

  1. Change in Depressive Symptoms

    Depressive symptoms were assessed using a depression scale before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  2. Change in Macular Pigment Level

    Macular pigment level was assessed using a macular pigment screener before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  3. Change in Ocular Surface Disease Symptoms

    Ocular surface disease symptoms were assessed using the Ocular Surface Disease Index before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  4. Change in Tear Film Parameters

    Tear film parameters were assessed using a non-contact ocular surface analyzer before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  5. Change in Contrast Sensitivity

    Contrast sensitivity was assessed using the CVS-1000 contrast sensitivity test before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  6. Change in Accommodative Microfluctuation

    Accommodative microfluctuation was assessed using an accommodative microfluctuation analyzer before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  7. Change in Retinal Structure

    Retinal structure was assessed using optical coherence tomography before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  8. Change in Cognitive Function

    Cognitive function was assessed using the Mini-Mental State Examination before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

  9. Change in Brain Magnetic Resonance Imaging Parameters

    Brain magnetic resonance imaging parameters were assessed before and after 30 days of gac fruit oil supplementation.

    Time frame: Baseline and 30 days

07

Study locations

1 site
  • Yuanpei University of Medical Technology
    Hsinchu, 30015, Taiwan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study data include health-related questionnaire responses, ophthalmic examination data, and brain magnetic resonance imaging data. Data were collected under the informed consent and confidentiality procedures approved by the institutional review board.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07623070
Lead sponsor
Yuanpei University of Medical Technology
Responsible party
Sponsor
First posted
Jun 3, 2026
Start date
Sep 1, 2022
Primary completion
Jul 16, 2023
Completion
Jul 16, 2023
Last update
Jun 3, 2026

Study contacts

Chao-Kai Chang
principal investigator · Yuanpei University of Medical Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion